Immune Design to Present at Upcoming Investor Conferences in February
February 03, 2014 08:00 ET
|
Immune Design Corp.
SEATTLE and SOUTH SAN FRANCISCO, Calif., Feb. 3, 2014 (GLOBE NEWSWIRE) -- Immune Design, a clinical-stage biotechnology company focused on the development of novel immune-based therapies for cancer...
Immune Design Appoints Frank J. Hsu, M.D., Vice President, Head of Oncology
October 24, 2013 08:00 ET
|
Immune Design Corp.
SAN FRANCISCO, Oct. 24, 2013 (GLOBE NEWSWIRE) -- Immune Design, a biotech company focused on the development of novel immune-based therapies for cancer and other human diseases, today announced the...
Immune Design Appoints Jan Henrik ter Meulen, M.D., Chief Scientific Officer
October 01, 2013 08:00 ET
|
Immune Design Corp.
SEATTLE and SAN FRANCISCO, Oct. 1, 2013 (GLOBE NEWSWIRE) -- Immune Design, a biotechnology company focused on the development of novel immune-based therapies for cancer and other chronic conditions,...
Immune Design Appoints Richard T. Kenney, M.D., Chief Medical Officer
September 05, 2013 08:00 ET
|
Immune Design Corp.
SEATTLE, Sept. 5, 2013 (GLOBE NEWSWIRE) -- Immune Design, a biotech company focused on the development of novel immune-based therapies for cancer and other human diseases, today announced the...
Immune Design Announces the Grant of Two Principle Technology Patents and a Recent Publication in the Proceedings of the National Academy of Sciences
October 09, 2012 07:30 ET
|
Immune Design Corp.
SEATTLE, Oct. 9, 2012 (GLOBE NEWSWIRE) -- Immune Design today announced that the United States Patent and Trademark Office (USPTO) has granted two patents covering both of the Company's principal...
Immune Design to Present at 3rd Annual Cancer Immunotherapy Conference
October 02, 2012 15:57 ET
|
Immune Design Corp.
SEATTLE, Oct. 2, 2012 (GLOBE NEWSWIRE) -- Immune Design today announced that the company will be presenting at the 3rd Annual Cancer Immunotherapy: A Long-Awaited Reality conference on Thursday,...
Immune Design Corp. Announces Appointment of Dr. Roger Perlmutter as a Member of Its Board of Directors
June 26, 2012 08:00 ET
|
Immune Design Corp.
SEATTLE, June 26, 2012 (GLOBE NEWSWIRE) -- Immune Design Corp. announced today the appointment of Roger M. Perlmutter, M.D., Ph.D., as a member of its Board of Directors. Dr. Perlmutter recently...